Connect with us

News

Moderna sues Pfizer/BioNTech over Covid-19 tech

Published

on

Moderna has filed a suit against Pfizer/BioNTech on the allegation that the Pfizer had copied two types of its intellectual property.

Morderna, which is US based, alleges that the mRNA technology it developed in 2010 before the pandemic was copied by Pfizer and its German partner BioNTech over its development of the first COVID-19 vaccine.

He alleged also that Pfizer infringed on the coding of the spike protein on the outside of the virus itself.

However, Pfizer has stated that it was “surprised” by the suit and would “vigorously defend” itself against the allegations.

“We are filing these lawsuits to protect the innovative mRNA technology platform that we pioneered, invested billions of dollars in creating, and patented during the decade preceding the Covid-19 pandemic,” Moderna chief executive Stephane Bancel said.

See also  Constructions above two-storey must obtain Insurance Certificate – Ogun Govt

Moderna, which was only formed as a company in 2010, said it was an early developer of the mRNA technology used commercially for the first time in Covid vaccines.

According to bbc.com, early in the pandemic, Moderna said it would not enforce its patents to help other drug companies develop their own jabs, particularly for low- and middle-income countries.

But in March 2022, it said rivals such as Pfizer and BioNTech would have to respect its intellectual property rights.

Patent lawsuits are common in the development of new technology and Moderna itself is being sued for alleged patent infringement in an ongoing dispute with the US National Institutes of Health.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Think About It

Role Model

Trending